Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

Market Cap	10.88B -2.1%
Revenue (ttm)	7.02B +3.4%
Net Income	927.66M +5.4%
EPS	5.18 +5.3%
Shares Out	178.70M
PE Ratio	11.76
Forward PE	n/a
Dividend	2.00 (3.28%)
Ex-Dividend Date	Aug 6, 2025

Volume	260,272
Average Volume	293,382
Open	61.00
Previous Close	61.00
Day's Range	60.30 - 61.00
52-Week Range	53.50 - 66.60
Beta	0.07
RSI	33.00
Earnings Date	May 7, 2026

About TPE:1720

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company o...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2025, TPE:1720's revenue was 7.02 billion, an increase of 3.44% compared to the previous year's 6.79 billion. Earnings were 927.66 million, an increase of 5.36%.